ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 245456 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 245456; 2) Community: the network communities that were significantly associated with the response to NSC 245456; 3) Molecule: the relationships between components within communities and NSC 245456; 4) MDR: the compounds that were significantly associated with the NSC 245456.

NSC Compound Enrichment Correlation
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0228801759885687 0.55274491
NSC 756053 Null 0.0228801759885687 -0.1599358
NSC 717189 Null 0.0238174255956146 0.10974808
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0238174255956147 0.26682593
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0238174255956147 0.30472432
NSC 39215 Null 0.0238174255956147 0.40803426
NSC 47468 Null 0.0238174255956147 0.16906071
NSC 603071 Aminocamptothecin 0.0238174255956147 -0.014927097
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0238174255956147 0.097047575
NSC 606497 Camptothecin Derivative 0.0238174255956147 -0.073127085
Total:74  Current:34    [First] [Prev] [Next] [Last]